Related Experiment Videos
[Rotavirus infections and their prevention with vaccines in children]
C Chippaux-Hyppolite1, G Loukou Yao, A Chippaux
1Laboratoires de Bactériologie-Virologie-Immunologie, Faculté de Médecine, Reims.
Insights
Developing an effective rotavirus vaccine is crucial for preventing severe diarrhea in young children globally. Challenges include rotavirus variability and evaluating vaccine efficacy amidst other pathogens.
Area of Science:
- Virology
- Immunology
- Pediatrics
Context:
- Human rotaviruses cause severe diarrhea in children under two in developing nations.
- Existing immunization schedules require safe, easily administered vaccines.
- Rotavirus's fragmented genome and antigenic variability pose vaccinal strategy challenges.
Purpose:
- To address the need for an effective rotavirus vaccine.
- To overcome difficulties in rotavirus vaccine development and evaluation.
- To improve rotavirus vaccine strategies for optimal efficacy.
Summary:
- Candidate rotavirus vaccines are live, orally administered, using bovine or simian strains.
- Recombinant and polyvalent strains are under evaluation.
- Research is ongoing for optimal dosing, target populations, and managing interference with other live vaccines.
Impact:
- Contradictory results from field trials highlight ongoing challenges.
- Further research aims to refine vaccine administration and target populations.
- Successful development will significantly reduce childhood diarrhea morbidity and mortality.
Abstract:
Human rotaviruses are the most common cause of severe diarrhoea in children under two years in developing countries: the need of an effective rotavirus vaccine, safe, easy to administer and compatible with existing immunization schedules is now well-established. Molecular structure of rotaviruses (fragmented genome) and their antigenic variability (four human serotypes without cross-reactivity) explain some difficulties in vaccinal strategy. Furthermore, specific efficacy is not clearly evaluable because many others pathogens are responsible of diarrhoea. Immunological response is influenced by serological status before immunization, antigenicity of vaccinal strains, age of immunization. For all these reasons, some contradictory results are emerging from published field trials. Present candidate rotavirus vaccines are live vaccines, with oral administration of bovine or simian rotaviruses; recombinant and polyvalent strains were constructed and were under evaluation; a better strategy for dose administration, target population and interference with other live vaccines is in progress.